PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosisLankin, Vadim Z.; Tikhaze, Alla K.; Chazova, Irina; Viigimaa, Margus7th Baltic Atherosclerosis Society Congress : [abstracts]2018 / p. 38-39 http://www.ester.ee/record=b4819912*est